Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.28452543 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.07863066 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.07863066 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.63794353 |
5 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.34954645 |
6 | detection of other organism (GO:0098543) | 4.26189289 |
7 | detection of bacterium (GO:0016045) | 4.22043959 |
8 | positive regulation of B cell differentiation (GO:0045579) | 4.15041609 |
9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.07719777 |
10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.99892249 |
11 | negative regulation of cell killing (GO:0031342) | 3.95834124 |
12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.95834124 |
13 | leukocyte aggregation (GO:0070486) | 3.89468322 |
14 | regulation of gamma-delta T cell activation (GO:0046643) | 3.85713766 |
15 | immunoglobulin mediated immune response (GO:0016064) | 3.84564302 |
16 | * positive regulation by symbiont of host defense response (GO:0052509) | 3.79305621 |
17 | * modulation by symbiont of host defense response (GO:0052031) | 3.79305621 |
18 | * modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.79305621 |
19 | * modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.79305621 |
20 | * positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.79305621 |
21 | * modulation by symbiont of host immune response (GO:0052553) | 3.79305621 |
22 | cellular extravasation (GO:0045123) | 3.72687720 |
23 | negative regulation of interleukin-12 production (GO:0032695) | 3.69057299 |
24 | positive thymic T cell selection (GO:0045059) | 3.65978617 |
25 | macrophage activation involved in immune response (GO:0002281) | 3.64233838 |
26 | detection of external biotic stimulus (GO:0098581) | 3.60214194 |
27 | negative regulation of granulocyte differentiation (GO:0030853) | 3.58461162 |
28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.57527793 |
29 | response to muramyl dipeptide (GO:0032495) | 3.56291062 |
30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.55559108 |
31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.51523273 |
32 | B cell receptor signaling pathway (GO:0050853) | 3.49182343 |
33 | neutrophil activation involved in immune response (GO:0002283) | 3.48093099 |
34 | regulation of B cell differentiation (GO:0045577) | 3.43228904 |
35 | positive regulation of interferon-alpha production (GO:0032727) | 3.43153203 |
36 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.41251912 |
37 | T cell migration (GO:0072678) | 3.36255991 |
38 | regulation of interferon-alpha production (GO:0032647) | 3.34758979 |
39 | response to peptidoglycan (GO:0032494) | 3.34609868 |
40 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.34176621 |
41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.31363873 |
42 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.30887242 |
43 | detection of molecule of bacterial origin (GO:0032490) | 3.28147326 |
44 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.27997128 |
45 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.20572015 |
46 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.19000895 |
47 | respiratory burst (GO:0045730) | 3.16997672 |
48 | regulation of T cell tolerance induction (GO:0002664) | 3.15946145 |
49 | detection of biotic stimulus (GO:0009595) | 3.15420465 |
50 | megakaryocyte development (GO:0035855) | 3.11122014 |
51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.09439990 |
52 | regulation of erythrocyte differentiation (GO:0045646) | 3.08880298 |
53 | pinocytosis (GO:0006907) | 3.06200103 |
54 | natural killer cell differentiation (GO:0001779) | 3.03800087 |
55 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.03047381 |
56 | leukocyte cell-cell adhesion (GO:0007159) | 3.02830751 |
57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.01190666 |
58 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97130393 |
59 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.96593295 |
60 | neutrophil activation (GO:0042119) | 2.95734152 |
61 | granulocyte activation (GO:0036230) | 2.94271404 |
62 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.92323818 |
63 | germinal center formation (GO:0002467) | 2.92168833 |
64 | response to interleukin-15 (GO:0070672) | 2.91382522 |
65 | regulation of tolerance induction (GO:0002643) | 2.90386913 |
66 | myeloid cell activation involved in immune response (GO:0002275) | 2.89727470 |
67 | B cell mediated immunity (GO:0019724) | 2.87724550 |
68 | negative thymic T cell selection (GO:0045060) | 2.86363723 |
69 | regulation of mast cell degranulation (GO:0043304) | 2.86109098 |
70 | macrophage activation (GO:0042116) | 2.85423566 |
71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.85213325 |
72 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.85099474 |
73 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.85099474 |
74 | thymic T cell selection (GO:0045061) | 2.83932621 |
75 | response to protozoan (GO:0001562) | 2.82909851 |
76 | regulation of mast cell activation (GO:0033003) | 2.82806837 |
77 | embryonic hemopoiesis (GO:0035162) | 2.81495740 |
78 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.81280364 |
79 | negative regulation of interleukin-6 production (GO:0032715) | 2.81063768 |
80 | T cell apoptotic process (GO:0070231) | 2.79040435 |
81 | B cell homeostasis (GO:0001782) | 2.77897446 |
82 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.76690437 |
83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75602669 |
84 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.74900418 |
85 | positive regulation of antigen processing and presentation (GO:0002579) | 2.73979113 |
86 | negative T cell selection (GO:0043383) | 2.73789504 |
87 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.73783992 |
88 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.73322648 |
89 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73021410 |
90 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.72721620 |
91 | regulation of regulated secretory pathway (GO:1903305) | 2.72607727 |
92 | defense response to protozoan (GO:0042832) | 2.72325783 |
93 | negative regulation of innate immune response (GO:0045824) | 2.72151374 |
94 | NIK/NF-kappaB signaling (GO:0038061) | 2.71634321 |
95 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.71364432 |
96 | positive regulation of mast cell activation (GO:0033005) | 2.70747945 |
97 | cellular response to interleukin-15 (GO:0071350) | 2.70597306 |
98 | mature B cell differentiation (GO:0002335) | 2.69556020 |
99 | actin nucleation (GO:0045010) | 2.68143419 |
100 | leukocyte degranulation (GO:0043299) | 2.67309095 |
101 | regulation of granulocyte differentiation (GO:0030852) | 2.65952127 |
102 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.65609530 |
103 | positive T cell selection (GO:0043368) | 2.65042834 |
104 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.64277187 |
105 | microglial cell activation (GO:0001774) | 2.63337206 |
106 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.63096472 |
107 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.62154402 |
108 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.61050787 |
109 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.60285708 |
110 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.60027296 |
111 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.59287979 |
112 | response to type I interferon (GO:0034340) | 2.59269740 |
113 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.58928708 |
114 | T cell selection (GO:0045058) | 2.58330103 |
115 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.57966232 |
116 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.57931433 |
117 | positive regulation of mast cell degranulation (GO:0043306) | 2.57931433 |
118 | granulocyte differentiation (GO:0030851) | 2.57557303 |
119 | negative regulation of B cell proliferation (GO:0030889) | 2.56943595 |
120 | regulation of antigen processing and presentation (GO:0002577) | 2.54574925 |
121 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.54446173 |
122 | protein localization to endosome (GO:0036010) | 2.53791145 |
123 | T-helper 1 type immune response (GO:0042088) | 2.52922080 |
124 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.52901982 |
125 | platelet formation (GO:0030220) | 2.52641643 |
126 | type I interferon signaling pathway (GO:0060337) | 2.51898968 |
127 | cellular response to type I interferon (GO:0071357) | 2.51898968 |
128 | regulation of leukocyte degranulation (GO:0043300) | 2.51104504 |
129 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.51079804 |
130 | T cell proliferation (GO:0042098) | 2.50985724 |
131 | positive regulation of macrophage differentiation (GO:0045651) | 2.50401107 |
132 | * lymphocyte homeostasis (GO:0002260) | 2.50032756 |
133 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.49928695 |
134 | mannose metabolic process (GO:0006013) | 2.49596742 |
135 | interferon-gamma production (GO:0032609) | 2.48363513 |
136 | positive regulation of interferon-beta production (GO:0032728) | 2.48268379 |
137 | signal complex assembly (GO:0007172) | 2.47727217 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.13590022 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.91535769 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.75687478 |
4 | * MYC_22102868_ChIP-Seq_BL_Human | 3.60656472 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.52647141 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.40644767 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.32620622 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.24614716 |
9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.20819430 |
10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.19977483 |
11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.16201646 |
12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.90591699 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81942956 |
14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.73134328 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70492595 |
16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62260052 |
17 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.41177455 |
18 | * MAF_26560356_Chip-Seq_TH1_Human | 2.40955286 |
19 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39006728 |
20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.35825486 |
21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.35670745 |
22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.34712287 |
23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.26131502 |
24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25383997 |
25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.23116005 |
26 | MYB_26560356_Chip-Seq_TH2_Human | 2.21337830 |
27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.18475076 |
28 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15247672 |
29 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10505782 |
30 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06599905 |
31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.06385810 |
32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03943839 |
33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.02871084 |
34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.02820387 |
35 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01793995 |
36 | * MYB_26560356_Chip-Seq_TH1_Human | 1.96796856 |
37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.94098571 |
38 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.91913176 |
39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.91807890 |
40 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.91685735 |
41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90728705 |
42 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.88833471 |
43 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.86270880 |
44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.86023001 |
45 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.84157547 |
46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71708372 |
47 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.69663722 |
48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67973537 |
49 | MAF_26560356_Chip-Seq_TH2_Human | 1.58803577 |
50 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.55180635 |
51 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50174002 |
52 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.49490328 |
53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48220395 |
54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.47247694 |
55 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46948117 |
56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45104255 |
57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43387505 |
58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39782931 |
59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36145222 |
60 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33393813 |
61 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30815032 |
62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28106697 |
63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27140392 |
64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26485018 |
65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26184680 |
66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23050938 |
67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22492371 |
68 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22374481 |
69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21923816 |
70 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21501809 |
71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19332768 |
72 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18608901 |
73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18170873 |
74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16637093 |
75 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14755447 |
76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13992782 |
77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13712094 |
78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13232912 |
79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10865787 |
80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10830600 |
81 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10319300 |
82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09431236 |
83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08905917 |
84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06514085 |
85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04436468 |
86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03881460 |
87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02934948 |
88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02903924 |
89 | P68_20966046_ChIP-Seq_HELA_Human | 1.00572079 |
90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00450912 |
91 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99953897 |
92 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.98962353 |
93 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98075581 |
94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97958803 |
95 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97893461 |
96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95041921 |
97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94144483 |
98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94022398 |
99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93605060 |
100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93178550 |
101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92197411 |
102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91193778 |
103 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88992375 |
104 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.88243602 |
105 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87438867 |
106 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85222069 |
107 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84937313 |
108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83175650 |
109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83137182 |
110 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82175499 |
111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81632495 |
112 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81332095 |
113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.81305595 |
114 | GATA3_26560356_Chip-Seq_TH2_Human | 0.79163327 |
115 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78984200 |
116 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.78762264 |
117 | ATF3_27146783_Chip-Seq_COLON_Human | 0.77829892 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 4.28511687 |
2 | MP0001835_abnormal_antigen_presentation | 3.23171256 |
3 | MP0003436_decreased_susceptibility_to | 3.18879743 |
4 | MP0000685_abnormal_immune_system | 2.82521249 |
5 | MP0001800_abnormal_humoral_immune | 2.78412737 |
6 | * MP0001790_abnormal_immune_system | 2.71973542 |
7 | * MP0005387_immune_system_phenotype | 2.71973542 |
8 | MP0009278_abnormal_bone_marrow | 2.56686576 |
9 | MP0002452_abnormal_antigen_presenting | 2.54527061 |
10 | * MP0005000_abnormal_immune_tolerance | 2.53205393 |
11 | MP0004510_myositis | 2.46235822 |
12 | MP0005671_abnormal_response_to | 2.45971401 |
13 | MP0002396_abnormal_hematopoietic_system | 2.45613477 |
14 | MP0002419_abnormal_innate_immunity | 2.42968960 |
15 | * MP0002723_abnormal_immune_serum | 2.36910275 |
16 | MP0005464_abnormal_platelet_physiology | 2.36837908 |
17 | MP0005025_abnormal_response_to | 2.33718732 |
18 | * MP0002420_abnormal_adaptive_immunity | 2.27336536 |
19 | * MP0001819_abnormal_immune_cell | 2.25981313 |
20 | MP0009785_altered_susceptibility_to | 2.24990836 |
21 | * MP0002398_abnormal_bone_marrow | 2.22137550 |
22 | * MP0003300_gastrointestinal_ulcer | 2.17564574 |
23 | MP0005397_hematopoietic_system_phenotyp | 2.15515011 |
24 | MP0001545_abnormal_hematopoietic_system | 2.15515011 |
25 | MP0000465_gastrointestinal_hemorrhage | 2.10141267 |
26 | MP0004808_abnormal_hematopoietic_stem | 2.09056183 |
27 | MP0009333_abnormal_splenocyte_physiolog | 2.08131037 |
28 | * MP0002405_respiratory_system_inflammati | 2.04276704 |
29 | * MP0000716_abnormal_immune_system | 1.96303514 |
30 | MP0002148_abnormal_hypersensitivity_rea | 1.95940695 |
31 | MP0003763_abnormal_thymus_physiology | 1.95442657 |
32 | MP0005451_abnormal_body_composition | 1.93977074 |
33 | MP0005058_abnormal_lysosome_morphology | 1.93373582 |
34 | * MP0000689_abnormal_spleen_morphology | 1.93131439 |
35 | * MP0002722_abnormal_immune_system | 1.86585682 |
36 | MP0004947_skin_inflammation | 1.86427672 |
37 | MP0008260_abnormal_autophagy | 1.83508788 |
38 | MP0010352_gastrointestinal_tract_polyps | 1.80910634 |
39 | MP0001533_abnormal_skeleton_physiology | 1.79136507 |
40 | * MP0006082_CNS_inflammation | 1.75808126 |
41 | MP0009840_abnormal_foam_cell | 1.75697153 |
42 | * MP0002429_abnormal_blood_cell | 1.71677262 |
43 | MP0005076_abnormal_cell_differentiation | 1.68352841 |
44 | * MP0010155_abnormal_intestine_physiology | 1.67461224 |
45 | MP0003724_increased_susceptibility_to | 1.67067583 |
46 | MP0001853_heart_inflammation | 1.66835087 |
47 | MP0001873_stomach_inflammation | 1.63081721 |
48 | MP0003172_abnormal_lysosome_physiology | 1.61091002 |
49 | * MP0001845_abnormal_inflammatory_respons | 1.60861958 |
50 | MP0002166_altered_tumor_susceptibility | 1.59208710 |
51 | MP0010307_abnormal_tumor_latency | 1.57454088 |
52 | MP0000703_abnormal_thymus_morphology | 1.57162787 |
53 | MP0003191_abnormal_cellular_cholesterol | 1.56147125 |
54 | MP0003566_abnormal_cell_adhesion | 1.51829463 |
55 | MP0002933_joint_inflammation | 1.47855658 |
56 | MP0003448_altered_tumor_morphology | 1.41971022 |
57 | MP0000343_altered_response_to | 1.41478047 |
58 | MP0003705_abnormal_hypodermis_morpholog | 1.36128931 |
59 | * MP0008469_abnormal_protein_level | 1.23930494 |
60 | * MP0000490_abnormal_crypts_of | 1.19111000 |
61 | MP0002006_tumorigenesis | 1.17033658 |
62 | MP0000858_altered_metastatic_potential | 1.16314146 |
63 | MP0008004_abnormal_stomach_pH | 1.15366449 |
64 | MP0002998_abnormal_bone_remodeling | 1.13565059 |
65 | MP0004883_abnormal_blood_vessel | 1.10429409 |
66 | MP0005023_abnormal_wound_healing | 1.09030544 |
67 | MP0003828_pulmonary_edema | 1.08762804 |
68 | MP0001958_emphysema | 1.07637431 |
69 | * MP0003866_abnormal_defecation | 1.04978079 |
70 | MP0008438_abnormal_cutaneous_collagen | 1.03118768 |
71 | MP0005164_abnormal_response_to | 1.02266272 |
72 | * MP0001851_eye_inflammation | 1.00938093 |
73 | MP0008961_abnormal_basal_metabolism | 0.97763842 |
74 | MP0003656_abnormal_erythrocyte_physiolo | 0.95022678 |
75 | MP0001849_ear_inflammation | 0.92510976 |
76 | MP0005174_abnormal_tail_pigmentation | 0.91847295 |
77 | * MP0002019_abnormal_tumor_incidence | 0.91314064 |
78 | MP0005390_skeleton_phenotype | 0.89683957 |
79 | MP0001915_intracranial_hemorrhage | 0.89140464 |
80 | * MP0005310_abnormal_salivary_gland | 0.89133353 |
81 | MP0002877_abnormal_melanocyte_morpholog | 0.87452055 |
82 | MP0004381_abnormal_hair_follicle | 0.86384473 |
83 | MP0003453_abnormal_keratinocyte_physiol | 0.85928310 |
84 | MP0002132_abnormal_respiratory_system | 0.82396442 |
85 | MP0006054_spinal_hemorrhage | 0.82255319 |
86 | MP0003091_abnormal_cell_migration | 0.81804996 |
87 | MP0003279_aneurysm | 0.81357909 |
88 | MP0009764_decreased_sensitivity_to | 0.80689247 |
89 | MP0003111_abnormal_nucleus_morphology | 0.79613766 |
90 | MP0003690_abnormal_glial_cell | 0.77253593 |
91 | MP0003075_altered_response_to | 0.77089103 |
92 | MP0005166_decreased_susceptibility_to | 0.76313299 |
93 | MP0003183_abnormal_peptide_metabolism | 0.75395493 |
94 | MP0003795_abnormal_bone_structure | 0.75125386 |
95 | MP0004185_abnormal_adipocyte_glucose | 0.74335169 |
96 | MP0000733_abnormal_muscle_development | 0.72846072 |
97 | * MP0001663_abnormal_digestive_system | 0.72651551 |
98 | MP0000604_amyloidosis | 0.71797411 |
99 | MP0009763_increased_sensitivity_to | 0.70342631 |
100 | MP0003077_abnormal_cell_cycle | 0.68791800 |
101 | MP0000767_abnormal_smooth_muscle | 0.68623259 |
102 | MP0001542_abnormal_bone_strength | 0.67568386 |
103 | MP0003045_fibrosis | 0.66660826 |
104 | MP0009931_abnormal_skin_appearance | 0.66092621 |
105 | * MP0000249_abnormal_blood_vessel | 0.65884820 |
106 | MP0002254_reproductive_system_inflammat | 0.64345914 |
107 | MP0008874_decreased_physiological_sensi | 0.64189915 |
108 | * MP0000313_abnormal_cell_death | 0.63484216 |
109 | MP0000569_abnormal_digit_pigmentation | 0.61775167 |
110 | MP0004858_abnormal_nervous_system | 0.61614275 |
111 | MP0008873_increased_physiological_sensi | 0.59420829 |
112 | MP0002138_abnormal_hepatobiliary_system | 0.58499169 |
113 | MP0005621_abnormal_cell_physiology | 0.58405417 |
114 | MP0008007_abnormal_cellular_replicative | 0.56829117 |
115 | MP0000350_abnormal_cell_proliferation | 0.56442397 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.97243518 |
2 | Recurrent abscess formation (HP:0002722) | 4.77663590 |
3 | Recurrent bacterial skin infections (HP:0005406) | 4.16920159 |
4 | Cellulitis (HP:0100658) | 4.08753478 |
5 | Recurrent fungal infections (HP:0002841) | 3.87751942 |
6 | Petechiae (HP:0000967) | 3.87512631 |
7 | IgM deficiency (HP:0002850) | 3.71012176 |
8 | Recurrent viral infections (HP:0004429) | 3.68381393 |
9 | Chronic otitis media (HP:0000389) | 3.58289206 |
10 | Spontaneous hematomas (HP:0007420) | 3.57493285 |
11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.56658494 |
12 | Myositis (HP:0100614) | 3.45125665 |
13 | Prolonged bleeding time (HP:0003010) | 3.39932834 |
14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.34957867 |
15 | Inflammation of the large intestine (HP:0002037) | 3.31483283 |
16 | Gastrointestinal inflammation (HP:0004386) | 3.29275321 |
17 | Increased cerebral lipofuscin (HP:0011813) | 3.27289528 |
18 | Mediastinal lymphadenopathy (HP:0100721) | 3.26760703 |
19 | Abnormality of macrophages (HP:0004311) | 3.23334382 |
20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.15522703 |
21 | Meningitis (HP:0001287) | 3.14079666 |
22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.11450594 |
23 | Obstructive lung disease (HP:0006536) | 3.11450594 |
24 | Impaired platelet aggregation (HP:0003540) | 3.09709713 |
25 | Abnormal platelet function (HP:0011869) | 3.09709713 |
26 | Recurrent skin infections (HP:0001581) | 2.99923023 |
27 | Nasal polyposis (HP:0100582) | 2.97250222 |
28 | Colitis (HP:0002583) | 2.94686271 |
29 | Gastrointestinal infarctions (HP:0005244) | 2.89898031 |
30 | Stomatitis (HP:0010280) | 2.89873324 |
31 | Systemic lupus erythematosus (HP:0002725) | 2.86785924 |
32 | Panhypogammaglobulinemia (HP:0003139) | 2.84775747 |
33 | Abnormality of the nasal mucosa (HP:0000433) | 2.83714043 |
34 | Papilloma (HP:0012740) | 2.80600042 |
35 | Verrucae (HP:0200043) | 2.80600042 |
36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.79706412 |
37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.79706412 |
38 | Recurrent bronchitis (HP:0002837) | 2.78938892 |
39 | Orchitis (HP:0100796) | 2.78243770 |
40 | Autoimmune thrombocytopenia (HP:0001973) | 2.78202657 |
41 | Pustule (HP:0200039) | 2.76462323 |
42 | Interstitial pulmonary disease (HP:0006530) | 2.75365922 |
43 | Vasculitis (HP:0002633) | 2.73815981 |
44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.69958186 |
45 | Agammaglobulinemia (HP:0004432) | 2.65794364 |
46 | Epistaxis (HP:0000421) | 2.61511274 |
47 | Increased IgE level (HP:0003212) | 2.59857848 |
48 | Abnormality of the fingertips (HP:0001211) | 2.59615508 |
49 | Osteomyelitis (HP:0002754) | 2.59251278 |
50 | Hematochezia (HP:0002573) | 2.58217594 |
51 | Encephalitis (HP:0002383) | 2.56348685 |
52 | Vacuolated lymphocytes (HP:0001922) | 2.51910014 |
53 | Dysostosis multiplex (HP:0000943) | 2.50507645 |
54 | Peritonitis (HP:0002586) | 2.49711230 |
55 | Gingival bleeding (HP:0000225) | 2.45921261 |
56 | Gingivitis (HP:0000230) | 2.45326316 |
57 | Cerebral aneurysm (HP:0004944) | 2.44673085 |
58 | Abnormality of T cells (HP:0002843) | 2.43714897 |
59 | Leukocytosis (HP:0001974) | 2.43561793 |
60 | Arterial thrombosis (HP:0004420) | 2.42746361 |
61 | Abnormal platelet volume (HP:0011876) | 2.41221070 |
62 | Thrombocytosis (HP:0001894) | 2.40862660 |
63 | Urticaria (HP:0001025) | 2.39833283 |
64 | T lymphocytopenia (HP:0005403) | 2.36756102 |
65 | Abnormality of T cell physiology (HP:0011840) | 2.35463699 |
66 | Chest pain (HP:0100749) | 2.31363549 |
67 | Retrobulbar optic neuritis (HP:0100654) | 2.30528833 |
68 | Optic neuritis (HP:0100653) | 2.30528833 |
69 | Hypochromic anemia (HP:0001931) | 2.29884020 |
70 | Periodontitis (HP:0000704) | 2.29535842 |
71 | Episodic fever (HP:0001954) | 2.27758216 |
72 | Abnormality of T cell number (HP:0011839) | 2.27442833 |
73 | Polycythemia (HP:0001901) | 2.26559703 |
74 | Keratoconjunctivitis sicca (HP:0001097) | 2.25681125 |
75 | Increased IgM level (HP:0003496) | 2.25313422 |
76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23731564 |
77 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23731564 |
78 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23731564 |
79 | Amyloidosis (HP:0011034) | 2.20286215 |
80 | Mucopolysacchariduria (HP:0008155) | 2.13148155 |
81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13148155 |
82 | Lymphopenia (HP:0001888) | 2.11657151 |
83 | Pulmonary infiltrates (HP:0002113) | 2.10789832 |
84 | Gastrointestinal stroma tumor (HP:0100723) | 2.10734016 |
85 | Myocardial infarction (HP:0001658) | 2.10377554 |
86 | Granulocytopenia (HP:0001913) | 2.08684704 |
87 | Hypergammaglobulinemia (HP:0010702) | 2.08533610 |
88 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.08377164 |
89 | Loss of speech (HP:0002371) | 2.05963797 |
90 | Emphysema (HP:0002097) | 2.05850951 |
91 | Menorrhagia (HP:0000132) | 2.05735306 |
92 | Osteolytic defects of the hand bones (HP:0009699) | 2.04936857 |
93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04936857 |
94 | Keratoconjunctivitis (HP:0001096) | 2.04911954 |
95 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04639237 |
96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04639237 |
97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04639237 |
98 | Thyroiditis (HP:0100646) | 2.04583994 |
99 | Hepatosplenomegaly (HP:0001433) | 2.04360267 |
100 | Fatigue (HP:0012378) | 2.04305493 |
101 | Disinhibition (HP:0000734) | 2.03216596 |
102 | Dilatation of the ascending aorta (HP:0005111) | 1.99989867 |
103 | Skin ulcer (HP:0200042) | 1.99508755 |
104 | Pulmonary embolism (HP:0002204) | 1.99459014 |
105 | Hypochromic microcytic anemia (HP:0004840) | 1.99419027 |
106 | Eosinophilia (HP:0001880) | 1.96466350 |
107 | Thoracic kyphosis (HP:0002942) | 1.96241664 |
108 | Abnormality of the peritoneum (HP:0002585) | 1.95869305 |
109 | Increased mean platelet volume (HP:0011877) | 1.95267252 |
110 | Glomerulonephritis (HP:0000099) | 1.92848663 |
111 | Spondylolisthesis (HP:0003302) | 1.92406180 |
112 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92239824 |
113 | Purpura (HP:0000979) | 1.91415309 |
114 | Protrusio acetabuli (HP:0003179) | 1.91120414 |
115 | Hemoptysis (HP:0002105) | 1.90702534 |
116 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89941410 |
117 | Sepsis (HP:0100806) | 1.89660518 |
118 | Hypertensive crisis (HP:0100735) | 1.89208708 |
119 | Restrictive lung disease (HP:0002091) | 1.88612420 |
120 | Abnormality of iron homeostasis (HP:0011031) | 1.88189874 |
121 | Vertebral compression fractures (HP:0002953) | 1.87729986 |
122 | IgA deficiency (HP:0002720) | 1.87642952 |
123 | Increased serum ferritin (HP:0003281) | 1.85420625 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.58830235 |
2 | EEF2K | 3.42941161 |
3 | PRPF4B | 3.41241418 |
4 | MAP3K10 | 3.11737004 |
5 | ERN1 | 3.04535215 |
6 | TRIB3 | 2.88584610 |
7 | PKN2 | 2.50221961 |
8 | BLK | 2.35696518 |
9 | STK10 | 2.23661715 |
10 | TYK2 | 2.15089823 |
11 | ZAP70 | 2.04579712 |
12 | TBK1 | 1.97113783 |
13 | JAK3 | 1.88405350 |
14 | MAP3K13 | 1.88072427 |
15 | CDK12 | 1.84608586 |
16 | TXK | 1.83800890 |
17 | GRK6 | 1.83688982 |
18 | EPHB1 | 1.81379537 |
19 | TGFBR2 | 1.80294618 |
20 | KIT | 1.74409885 |
21 | SMG1 | 1.72451976 |
22 | BTK | 1.72125558 |
23 | TAOK2 | 1.60808040 |
24 | IRAK4 | 1.57347787 |
25 | LRRK2 | 1.55728149 |
26 | CSF1R | 1.51347219 |
27 | SIK2 | 1.47993770 |
28 | HCK | 1.42436895 |
29 | MAP2K3 | 1.41006833 |
30 | IRAK3 | 1.40680849 |
31 | SYK | 1.37990672 |
32 | PTK6 | 1.37250700 |
33 | FES | 1.37228004 |
34 | MAP3K14 | 1.37226975 |
35 | TAOK3 | 1.36488094 |
36 | CSK | 1.32276410 |
37 | KDR | 1.32222713 |
38 | JAK1 | 1.29610591 |
39 | IKBKB | 1.26872187 |
40 | IKBKE | 1.26820961 |
41 | RPS6KA4 | 1.26744911 |
42 | MAP3K1 | 1.24500512 |
43 | PIM1 | 1.24492871 |
44 | CLK1 | 1.22073533 |
45 | PRKD2 | 1.21692609 |
46 | RIPK4 | 1.20960989 |
47 | CDC42BPA | 1.16894201 |
48 | PIM2 | 1.15278904 |
49 | ITK | 1.13572713 |
50 | LCK | 1.08544697 |
51 | KSR2 | 1.07862431 |
52 | BMX | 1.07138871 |
53 | MARK2 | 1.03691722 |
54 | ALK | 1.00729498 |
55 | CDK4 | 0.96386892 |
56 | TEC | 0.95295903 |
57 | CAMK1D | 0.95158094 |
58 | MAP3K11 | 0.94846815 |
59 | PAK4 | 0.93561698 |
60 | CHUK | 0.93484893 |
61 | TTN | 0.92830826 |
62 | CDK6 | 0.91827977 |
63 | LYN | 0.89066187 |
64 | SCYL2 | 0.88229539 |
65 | NEK2 | 0.87733945 |
66 | TESK2 | 0.86337010 |
67 | JAK2 | 0.86290554 |
68 | FGFR3 | 0.84783373 |
69 | PDPK1 | 0.83901492 |
70 | FGFR4 | 0.83579215 |
71 | MARK3 | 0.81141120 |
72 | STK24 | 0.80855529 |
73 | PDK1 | 0.79180530 |
74 | MAPK12 | 0.78712529 |
75 | TAOK1 | 0.77558107 |
76 | MAPK7 | 0.74728541 |
77 | CAMK1G | 0.74726625 |
78 | TNK2 | 0.74703639 |
79 | STK3 | 0.74311228 |
80 | STK4 | 0.73646812 |
81 | IRAK2 | 0.70559251 |
82 | SIK1 | 0.70236143 |
83 | MAP3K8 | 0.70051024 |
84 | TRPM7 | 0.69463510 |
85 | MOS | 0.67826432 |
86 | RIPK1 | 0.62068095 |
87 | DMPK | 0.61470650 |
88 | BMPR2 | 0.61166181 |
89 | NME2 | 0.58951799 |
90 | MAPKAPK2 | 0.58631154 |
91 | HIPK2 | 0.57756879 |
92 | RPS6KA6 | 0.56807913 |
93 | IRAK1 | 0.56397298 |
94 | MAP3K6 | 0.55696413 |
95 | PRKG2 | 0.55431891 |
96 | MAPK4 | 0.53476652 |
97 | MATK | 0.53137561 |
98 | FLT3 | 0.53075429 |
99 | MAP3K3 | 0.51504185 |
100 | SIK3 | 0.50692183 |
101 | PTK2B | 0.50059251 |
102 | YES1 | 0.49516530 |
103 | PRKCH | 0.48982492 |
104 | CDK9 | 0.47123380 |
105 | RPS6KL1 | 0.46528683 |
106 | RPS6KC1 | 0.46528683 |
107 | FYN | 0.46298967 |
108 | BRD4 | 0.46194505 |
109 | RET | 0.45268925 |
110 | EPHA3 | 0.44803040 |
111 | MTOR | 0.44663353 |
112 | CAMKK1 | 0.43742154 |
113 | PDGFRA | 0.42967932 |
114 | EGFR | 0.42937158 |
115 | RPS6KB2 | 0.42873379 |
116 | GRK7 | 0.42448555 |
117 | STK38 | 0.41517350 |
118 | ARAF | 0.41269867 |
119 | PDGFRB | 0.41262177 |
120 | FGR | 0.40520142 |
121 | MAPK11 | 0.39925354 |
122 | RPS6KA2 | 0.39863517 |
123 | TESK1 | 0.38521232 |
124 | ABL1 | 0.37663920 |
125 | MAP3K7 | 0.37040528 |
126 | ICK | 0.35943469 |
127 | PAK2 | 0.35215101 |
128 | RPS6KA1 | 0.34880405 |
129 | TGFBR1 | 0.34151914 |
130 | NLK | 0.31343735 |
Rank | Gene Set | Z-score |
---|---|---|
1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.68795936 |
2 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.57866072 |
3 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49776617 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.41397337 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.25481875 |
6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.09671810 |
7 | Measles_Homo sapiens_hsa05162 | 2.06762898 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98543299 |
9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94535342 |
10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.91165551 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89262029 |
12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.83525821 |
13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.80650340 |
14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.79437398 |
15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.79043939 |
16 | Asthma_Homo sapiens_hsa05310 | 1.73074351 |
17 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68977485 |
18 | Shigellosis_Homo sapiens_hsa05131 | 1.67870810 |
19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.66318926 |
20 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.65513617 |
21 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.65276107 |
22 | Pertussis_Homo sapiens_hsa05133 | 1.61859120 |
23 | * Tuberculosis_Homo sapiens_hsa05152 | 1.59845173 |
24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.57742553 |
25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53624262 |
26 | Apoptosis_Homo sapiens_hsa04210 | 1.53188703 |
27 | Legionellosis_Homo sapiens_hsa05134 | 1.49301925 |
28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45757970 |
29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44506020 |
30 | Influenza A_Homo sapiens_hsa05164 | 1.42751788 |
31 | Allograft rejection_Homo sapiens_hsa05330 | 1.42509012 |
32 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42183382 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42136051 |
34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41168674 |
35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38182073 |
36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37616654 |
37 | * Hepatitis B_Homo sapiens_hsa05161 | 1.37389000 |
38 | * Malaria_Homo sapiens_hsa05144 | 1.35053470 |
39 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31884819 |
40 | Lysosome_Homo sapiens_hsa04142 | 1.31730714 |
41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31598622 |
42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.29496016 |
43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26421023 |
44 | Platelet activation_Homo sapiens_hsa04611 | 1.26207405 |
45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23319180 |
46 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21928917 |
47 | Salmonella infection_Homo sapiens_hsa05132 | 1.17975212 |
48 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.12725703 |
49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12675398 |
50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11262703 |
51 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06012743 |
52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03925202 |
53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03532723 |
54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03018100 |
55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00118945 |
56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98663668 |
57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96949406 |
58 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.95664863 |
59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95034349 |
60 | Bladder cancer_Homo sapiens_hsa05219 | 0.93328913 |
61 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91874569 |
62 | Hepatitis C_Homo sapiens_hsa05160 | 0.88798746 |
63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88358827 |
64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87023976 |
65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83773026 |
66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81006912 |
67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80615270 |
68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78093690 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.73111364 |
70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72546932 |
71 | Phagosome_Homo sapiens_hsa04145 | 0.69967388 |
72 | DNA replication_Homo sapiens_hsa03030 | 0.68829248 |
73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67635894 |
74 | * Endocytosis_Homo sapiens_hsa04144 | 0.67356481 |
75 | Insulin resistance_Homo sapiens_hsa04931 | 0.66367020 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65284843 |
77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64666028 |
78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62256010 |
79 | Lysine degradation_Homo sapiens_hsa00310 | 0.60991068 |
80 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60705080 |
81 | * Amoebiasis_Homo sapiens_hsa05146 | 0.60327204 |
82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59441097 |
83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58609675 |
84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58537344 |
85 | * Colorectal cancer_Homo sapiens_hsa05210 | 0.58499242 |
86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57265026 |
87 | Focal adhesion_Homo sapiens_hsa04510 | 0.56567986 |
88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55630475 |
89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55521123 |
90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54482428 |
91 | Base excision repair_Homo sapiens_hsa03410 | 0.54211028 |
92 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53943334 |
93 | Glioma_Homo sapiens_hsa05214 | 0.53497252 |
94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53395826 |
95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52414636 |
96 | Prostate cancer_Homo sapiens_hsa05215 | 0.51122877 |
97 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50454901 |
98 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50218810 |
99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49920940 |
100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48935874 |
101 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47655837 |
102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47287915 |
103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40865988 |
104 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39181876 |
105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39103162 |
106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38119027 |
107 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.38108853 |
108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36856626 |
109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36456115 |
110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35281121 |
111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35223438 |
112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35151314 |
113 | Adherens junction_Homo sapiens_hsa04520 | 0.33829677 |
114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33747385 |